Teva Pharmaceutical (TEVA) -1.4% after the FDA publicized "significant" manufacturing violations...

|About: Teva Pharmaceutical Ind... (TEVA)|By:, SA News Editor

Teva Pharmaceutical (TEVA) -1.4% after the FDA publicized "significant" manufacturing violations at a facility that makes the injected sedative propofol. Teva failed to test raw materials for bacterial endotoxin, and released contaminated vials which were later recalled. APP Pharma, a subsidiary of Fresenius Kabi (APCVZ), is currently importing unapproved Propoven to cope with the propofol shortage.